RenovoRx Inc

RenovoRx Inc(RNXT)价格预测

$1.135

-0.052 (-4.62%)收盘时

价格预测

1-Day Price Prediction
-0.91%
1-Week Prediction
-4.05%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

在 App 中打开以解锁更长周期的预测。

Loading chart…

RNXT 相似图表分析预测

Alphio's RNXT stock price prediction model matches the current RenovoRx Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.12 (-0.91%). The 1-week path is $1.09 (-4.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 RenovoRx Inc 股票吗?

RenovoRx Inc is a good buy right now due to its recent strong revenue growth and positive clinical trial results. The stock closed at $1.26, which is significantly below the analyst price target of $14.50, indicating a potential upside of over 1,000%. Additionally, the company reported a record revenue of $909,000 for Q2 2026, reflecting a 61% sequential increase and a 115% year-over-year rise. The main risk is the negative earnings per share (EPS) of -0.06 reported for Q2 2026, which indicates ongoing losses but is improving compared to previous quarters.

RNXT 股价于 Friday 收于 $1.14,此前下跌 -4.62%

RenovoRx Inc (RNXT) last closed at $1.135, losing -4.62%. These facts feed the 1-day and 1-week RNXT price prediction above.

预测驱动因素

RenovoRx Inc(RNXT)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Positive

Bullish

相似图表形态

近期走势与 RNXT 最接近的股票,按相似度排序。

RNXT 季节性分析

Historically the probability of a positive November return for RNXT is 11.36%. June offers the highest probability of a positive month at 53.33%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易